iotaMotion gains paediatric FDA indication for cochlear implant robot
Robotics company iotaMotion has received a paediatric indication expansion for its robotic-assisted iotaSOFT cochlear implant insertion system from the US …
Post
-
-
JPM26: Medtech CEO says conference’s appeal in decline
As the curtain falls on the 44th edition of the J.P. Morgan Healthcare Conference in San Francisco, a medtech company …
-
VB Spine to acquire Robotron’s SpineHawk spinal visualisation platform
US-based medical technology company VB Spine has agreed to acquire the SpineHawk intraoperative spinal visualisation platform from Robotron Surgical Technologies. The …
-
BD secures FDA 510(k) clearance for EnCor EnCompass system
BD (Becton, Dickinson and Company) has received 510(k) approval from the US Food and Drug Administration (FDA) for the EnCor …
-
JPM26: Opus Genetics builds momentum in rare retinal gene therapy
Inherited retinal diseases encompass more than 350 genetic mutations and represent a significant unmet clinical need. Opus Genetics’ portfolio approach …
-
JPM26: Butterfly Network aims to close the global medical imaging gap
Butterfly Network currently boasts the world’s largest installed base of point-of-care ultrasound (POCUS) devices, with its technology being utilised globally, …
-
JPM26: Rakuten Medical unveils transformative photoimmunotherapy platform
Rakuten Medical’s presentation at the J.P. Morgan Healthcare Conference 2026 delivered a clear message: the future of cancer care will …
-
JPM26: Boston Scientific acquires Penumbra in $14.5bn deal
Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech …
-
MedTech’s invisible enemy: The growing challenge of electromagnetic interference
Electromagnetic interference (EMI), which refers to the disturbance of a device’s performance by an unwanted electromagnetic field, is a serious …
-
JPM26: Intuitive’s stock falls despite positive FY25 financials
Robotic surgery giant Intuitive’s stock has fallen despite reporting positive growth in its full year 2025 (FY25) and Q4 financials. Ahead …
-
JPM26: ICU Medical hopeful to ‘get out of the woods’ soon
During ICU Medical’s company presentation, the company highlighted that intravenous (IV) therapy is essential care and products are deeply embedded …
-
JPM26: Integra resets by fixing supply and riding reimbursement tailwinds
Integra LifeSciences used its update at the ongoing 2026 J.P. Morgan Healthcare Conference in San Francisco to frame 2025 and …
-
JPM26: Ambu strengthens growth outlook as single-use endoscopy adoption grows
Ambu reaffirmed its long-term growth strategy focused on expanding single-use endoscopy, highlighting strong clinical adoption, improving hospital economics, and ongoing …
-
Intuitive Surgical expands platforms despite market headwind
At the 2026 JP Morgan Healthcare Conference, Intuitive Surgical outlined how its portfolio of robotic surgical systems continued to grow …
-
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US
Zimmer Biomet announced plans to continue developing its robotic platforms and investing in a stronger, specialised sales force in the …
